Radiofrequency vapor ablation for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new device that uses radiofrequency energy to treat the lining of the upper small intestine in people with type 2 diabetes. The goal is to see if this treatment is safe and helps improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 22 and 65 years old.
- You have had type 2 diabetes for at least 1 year but no more than 15 years.
- Your most recent HbA1c (average blood sugar) is between 7.5% and 10%.
- Your BMI is between 24 and 40.
- You are on at least one non-insulin diabetes medication (like metformin, GLP-1s, or sulfonylureas) and your dose has been stable for at least 12 weeks.
- You are willing to use a continuous glucose monitor and follow all study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This trial tests whether a procedure that uses heat energy (radiofrequency vapor ablation) applied in the first part of the small intestine (duodenum) can improve blood sugar control in adults with type 2 diabetes. It may help lower blood sugar when standard oral medicines are not keeping it in range.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
This trial tests a new way to treat type 2 diabetes by using a thin, flexible tube with a small band to gently tighten part of the stomach and intestine. It's for people with diabetes who are overweight and whose blood sugar isn't well controlled with pills alone.
Hear when a new Type-2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.